MLEC
Moolec Science SAยทNASDAQ
--
--(--)
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MLEC
Moolec Science Sa
A leader in the use of molecular farming technology for developing food ingredients
89 Nexus Way
Camana Bay
Grand Cayman KY1-9009
Cayman Islands
--
Moolec Science SA was established on 23 May 2022 under the laws of the Grand Duchy of Luxembourg. Moolec is an integrated ingredients and food technology platform focused on producing alternative proteins through two complementary methods: molecular farming and precision fermentation. The company uses crops such as soybeans and safflower to advance molecular agriculture projects to produce proteins and lipids that mimic animal functions at plant-based costs. Meanwhile, Moolec is developing a precision fermentation facility in Finland under the SynBio Powerlabs brand to produce target proteins, enzymes and biomolecules using an optimized microbial system. This dual approach improves time to market, spreads technical risk, and ensures production cost efficiency.
Company Financials
EPS
MLEC has released its 2025 Q1 earnings. EPS was reported at -0.07, versus the expected -0.06, missing expectations. The chart below visualizes how MLEC has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
MLEC has released its 2025 Q2 earnings report, with revenue of 2.64M, reflecting a YoY change of 948.32%, and net profit of -2.43M, showing a YoY change of -36.10%. The Sankey diagram below clearly presents MLEC's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
